Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses

NCT04348370 is registered in ClinicalTrials.gov with Texas A&M University as lead sponsor.

NCT NCT04348370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses
Lead sponsor
Texas A&M University
Phase
Phase 4
Overall status
Completed
Start date
April 20, 2020
Completion date
April 21, 2023
Enrollment
659 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, coronavirus as the cause of diseases classified elsewhere, coronavirus infection